{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:47:50Z","timestamp":1792698470703,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":4206,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1600-6143.2011.03558.x","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T16:53:46Z","timestamp":1305219226000},"page":"1148-1157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":199,"title":["Generation and Large-Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft-Versus-Host Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"K.L.","family":"Hippen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.K.","family":"Schirm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.C.","family":"Tennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"June","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.R.","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2011.03558.x_bib1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nri2137","article-title":"What does the future hold for cell-based tolerogenic therapy?","volume":"7","author":"Bluestone","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri2138","article-title":"Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans","volume":"7","author":"Roncarolo","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.immuni.2009.04.006","article-title":"Human T regulatory cell therapy: Take a billion or so and call me in the morning","volume":"30","author":"Riley","year":"2009","journal-title":"Immunity"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10875-008-9242-z","article-title":"T regulatory cells in autoimmune diabetes: Past challenges, future prospects","volume":"28","author":"Bluestone","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4 (+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J Exp Med"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib6","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4 (+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2337\/db08-1168","article-title":"Expansion of human regulatory T-cells from patients with type 1 diabetes","volume":"58","author":"Putnam","year":"2009","journal-title":"Diabetes"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib9","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1182\/blood-2009-01-199950","article-title":"Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I\/II (CD121a\/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures","volume":"113","author":"Tran","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.it.2008.06.005","article-title":"Natural and TGF-beta-induced Foxp3(+)CD4 (+) CD25(+) regulatory T cells are not mirror images of each other","volume":"29","author":"Horwitz","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib11","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.4049\/jimmunol.181.4.2277","article-title":"Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression","volume":"181","author":"Xiao","year":"2008","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib12","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.4049\/jimmunol.179.6.3724","article-title":"Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells","volume":"179","author":"Kang","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib13","doi-asserted-by":"crossref","first-page":"e15868","DOI":"10.1371\/journal.pone.0015868","article-title":"Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells","volume":"6","author":"Golovina","year":"2011","journal-title":"PLoS One"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib14","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1126\/science.1164511","article-title":"Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero","volume":"322","author":"Mold","year":"2008","journal-title":"Science"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib15","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood-2007-06-094656","article-title":"Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype","volume":"110","author":"Tran","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib16","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.4049\/jimmunol.0901065","article-title":"De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid","volume":"183","author":"Wang","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib17","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.4049\/jimmunol.1000769","article-title":"Combined administration of a mutant TGF-beta1\/Fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance","volume":"185","author":"Zhang","year":"2010","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/mt.sj.6300134","article-title":"Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules","volume":"15","author":"Suhoski","year":"2007","journal-title":"Mol Ther"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib19","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2008-01-132951","article-title":"Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4\u20131BB expressed on artificial antigen-presenting cells","volume":"112","author":"Hippen","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1084\/jem.20042020","article-title":"The Pim kinases control rapamycin-resistant T cell survival and activation","volume":"201","author":"Fox","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib21","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.4049\/jimmunol.180.9.5794","article-title":"Cutting edge: Foxp3-mediated induction of Pim 2 allows human T regulatory cells to preferentially expand in rapamycin","volume":"180","author":"Basu","year":"2008","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2009-12-257253","article-title":"In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia","volume":"116","author":"Choi","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib23","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/eji.200939432","article-title":"Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD","volume":"39","author":"Koenecke","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib24","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.4049\/jimmunol.181.5.3137","article-title":"Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo","volume":"181","author":"Radhakrishnan","year":"2008","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib25","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.4049\/jimmunol.175.9.5732","article-title":"Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism","volume":"175","author":"Foley","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib26","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ni.1912","article-title":"The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27","volume":"11","author":"Apetoh","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.immuni.2010.11.022","article-title":"Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice","volume":"33","author":"Sharma","year":"2010","journal-title":"Immunity"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ni1437","article-title":"Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3","volume":"8","author":"Williams","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib29","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ni.1774","article-title":"Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo","volume":"10","author":"Zhou","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbmt.2008.06.007","article-title":"Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells","volume":"14","author":"Foley","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1677\/jme.1.01966","article-title":"FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor","volume":"36","author":"Yamaguchi","year":"2006","journal-title":"J Mol Endocrinol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib32","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1073\/pnas.041614198","article-title":"FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle","volume":"98","author":"Aghdasi","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib33","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/17826","article-title":"Inhibition of transforming growth factor-beta\/SMAD signalling by the interferon-gamma\/STAT pathway","volume":"397","author":"Ulloa","year":"1999","journal-title":"Nature"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4049\/jimmunol.0903412","article-title":"Cutting edge: The Th1 response inhibits the generation of peripheral regulatory T cells","volume":"184","author":"Caretto","year":"2010","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nri2474","article-title":"Epigenetic control of FOXP3 expression: The key to a stable regulatory T-cell lineage?","volume":"9","author":"Huehn","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1600-6143.2011.03558.x_bib36","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ni.1915","article-title":"Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells","volume":"11","author":"Gandhi","year":"2010","journal-title":"Nat Immunol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2011.03558.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522279635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522279635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2011.03558.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:52:59Z","timestamp":1761627179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522279635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1600613522279635"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03558.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and Large-Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft-Versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03558.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}